News

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
Diffuse Large B-Cell Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 70+ Companies and 75+ Therapies | DelveInsight
DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...
Nektar Therapeutics: 2 Data Readouts For REZPEG 2025 Could Establish Further POC
Nektar Therapeutics' REZPEG shows progress in treating atopic dermatitis & alopecia areata. Click here to find out why I rate ...
Medindia on MSN4d
Having a Dog May Reduce Childhood Eczema Risk
A New study finds that living with a dog early in life may protect kids from eczema, especially those with a higher genetic ...
Switching off key gene makes NK cells more sensitive to cancer-fighting signals
All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...
Equity Insider: As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...
Dogs may guard kids from common childhood illness and chronic diseases, here’s what new study says
Research indicates that early exposure to dogs may mitigate genetic risks associated with eczema in children. A specific gene variation linked to eczema could be neutralized by growing up with a dog, ...
Bolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...